2 news items
Actinium Pharmaceuticals (ATNM) Reveals Promising Results from SIERRA Trial at EHA Congress
ATNM
BMRN
EXEL
17 Jun 24
financial advice or an endorsement of ATNM or its strategies. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Please ensure to fully
MAIA Biotechnology (MAIA): Pioneering New Frontiers in NSCLC Treatment with THIO
BMRN
EXEL
GMAB
7 Jun 24
: This blog post is for informational purposes only and does not constitute financial advice or an endorsement of MAIA or its strategies. FOR EDUCATIONAL
- Prev
- 1
- Next